The Global Vaccines Market is a cornerstone of modern public health and one of the most dynamic sectors in the biopharmaceutical industry. As we move into 2026, the market is characterized by a rapid shift toward mRNA technology, increased focus on adult immunization, and a robust pipeline for previously "un-vaccinatable" diseases like Malaria and certain cancers. https://www.databridgemarketresearch.com/